Detailed answers about AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED, including incorporation, status, business activity, and accounts information.
When was AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED founded?
AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED was officially incorporated on 23 June 1995 and is registered under company number 03071923. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED?
AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED do?
AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED operates in the following sector: 46460 - Wholesale of pharmaceutical goods. This provides insight into the company's primary business activity and industry focus.
What is AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED's registered address?
The registered office address of AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED is SUITE 1B1 ARGYLE HOUSE, NORTHSIDE, JOEL STREET, NORTHWOOD, MIDDLESEX, UNITED KINGDOM, HA6 1NW. This is the official address filed with Companies House for legal and statutory correspondence.
Is AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED financially stable?
The most recent accounts for AMERICAN BIOCHEMICAL AND PHARMACEUTICALS LIMITED were made up to 30 September 2025, filed as UNAUDITED ABRIDGED. Next accounts are due by 30 June 2027.